Bio Techne Appoints Kim Kelderman As Chief Executive Officer
10/21/23, 9:58 AM
Location
minneapolis
Industry
biotechnology research
Position
president
chief executive officer
MINNEAPOLIS, Oct. 19, 2023 /PRNewswire/ -- Bio-Techne Corporation today announced that its Board of Directors appointed Kim Kelderman as President and Chief Executive Officer effective February 1, 2024. Concurrent with his role as CEO, Mr
Company Info
Location
minneapolis, minnesota, united states
Additional Info
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers efficient and streamlined options for automated Western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers, as well as clinical research laboratories, and constitute the Protein Sciences Segment.